X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Increasing global access to vaccines by optimizing production

By Megan Van Etten  |    July 29, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.   Read More

Guest post: Retired medics return to the field to take on vaccine delivery and disaster relief

By Guest Contributor  |    July 23, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Guest Post: A patient’s story of the long-term health impacts of COVID-19

By Guest Contributor  |    July 21, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Dose sharing as a part of the COVID-19 global vaccine equity strategy

By Megan Van Etten  |    July 20, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.   Read More

Promoting global vaccine equity while protecting innovation

By Megan Van Etten  |    July 15, 2021
America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The...   Read More

Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

By Tom Wilbur  |    July 2, 2021
As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...   Read More

Americans 12 years of age and older are eligible for COVID-19 vaccines

By Gabby Migliara  |    June 17, 2021
Last month, the U.S. Food and Drug Administration (FDA) granted an expansion of an emergency use authorization on one of the COVID-19 vaccines allowing Americans 12-15 years of age and older to be...   Read More

ICYMI: PhRMA president and CEO Stephen J. Ubl joins other industry leaders for a conversation on COVID-19 vaccines with Axios

By Andrew Powaleny  |    May 21, 2021
On May 19, Axios hosted an event discussing the unprecedented development of COVID-19 vaccines and the road ahead. Speakers included NIAID Director Dr. Anthony Fauci, Pfizer Chairman & CEO Dr....   Read More

Supporting India during the devastating coronavirus surge

By Megan Van Etten  |    May 20, 2021
Like many others around the world, America’s biopharmaceutical companies stand with those affected by the coronavirus. And while biopharmaceutical companies are working around the clock to meet...   Read More

PhRMA CAREs Grant request for proposals: Addressing inequities in access to COVID-19 testing, therapeutics and vaccines

By Guest Contributor  |    May 6, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."